Engineered CD40-biosensor-expressing Treg cells as a cell therapy approach for inflammatory diseases

Bittner S, Schmidleithner L, Ruhland B, Hofmann V, Stuve P, Hoffmann F, Echtenacher B, Hoffmann P, Edinger M, Beilhack A, Strieder N, Hernandez-Lopez I, Rehli M, Hehlgans T, Feuerer M. Engineered CD40-biosensor-expressing Treg cells as a cell therapy approach for inflammatory diseases. Mol Ther. 2026 Apr 1. 34:2217–2235. doi:10.1016/j.ymthe.2026.01.002. PMID: 41521559